29 results
DEFA14A
ORTX
Orchard Therapeutics plc
5 Oct 23
Additional proxy soliciting materials
9:07am
or classified or that is otherwise regulated by any Governmental Authority with jurisdiction over the environment as hazardous, toxic, radioactive
8-K
EX-2.1
ORTX
Orchard Therapeutics plc
5 Oct 23
Kyowa Kirin to Acquire Orchard Therapeutics
9:05am
or that is otherwise regulated by any Governmental Authority with jurisdiction over the environment as hazardous, toxic, radioactive, dangerous, harmful
8-K
EX-1.1
7uaqp3
6 Oct 22
Entry into a Material Definitive Agreement
4:34pm
8-K
3zefgela9iknk
1 Jul 21
Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new and larger indications
5:02pm
8-K
EX-99.1
him4dh 0t2ig
1 Jul 21
Highlights the broader potential of Orchard’s ex vivo HSC gene therapy platform approach in new and larger indications
5:02pm
8-K
EX-10.1
hx1sicp 3q4jhzkm93hn
9 Feb 21
Orchard Therapeutics Announces $150 Million Strategic Financing
7:10am
POSASR
EX-1.2
u92cdfj1
28 Feb 20
Automatic shelf registration (post-effective amendment)
12:00am
10-K
iw4kf
27 Feb 20
Annual report
4:02pm
8-K
EX-99.2
nj0l5h82d8l5vic4 oka
13 Jan 20
Orchard Therapeutics Highlights 2020 Strategic Priorities
7:20am
F-1
EX-1.1
u9ktg
3 Jun 19
Registration statement (foreign)
4:33pm